Literature DB >> 29599110

Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome.

Chikako Ohwada1, Emiko Sakaida1, Chika Kawajiri-Manako1, Yuhei Nagao1, Nagisa Oshima-Hasegawa1, Emi Togasaki1,2, Tomoya Muto1, Shokichi Tsukamoto1, Shio Mitsukawa1,3, Yusuke Takeda1, Naoya Mimura1,3, Masahiro Takeuchi1, Naomi Shimizu4, Sonoko Misawa5, Tohru Iseki1,3, Satoshi Kuwabara5, Chiaki Nakaseko1,2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29599110      PMCID： PMC5946762          DOI： 10.1182/blood-2017-07-795385

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  15 in total

1.  A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale.

Authors:  R C Graham; R A C Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-30       Impact factor: 10.154

2.  Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome.

Authors:  Qian-Qian Cai; Chen Wang; Xin-Xin Cao; Hao Cai; Dao-Bin Zhou; Jian Li
Journal:  Eur J Haematol       Date:  2015-02-10       Impact factor: 2.997

3.  Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience.

Authors:  Anita D'Souza; Martha Lacy; Morie Gertz; Shaji Kumar; Francis Buadi; Suzanne Hayman; David Dingli; Steven Zeldenrust; Robert Kyle; Stephen Ansell; David Inwards; Patrick Johnston; Ivana Micallef; Luis Porrata; Mark Litzow; Dennis Gastineau; William Hogan; Angela Dispenzieri
Journal:  Blood       Date:  2012-05-18       Impact factor: 22.113

4.  Impact of pretransplant induction therapy on autologous stem cell transplantation for patients with newly diagnosed POEMS syndrome.

Authors:  J Li; M-H Duan; C Wang; X-F Huang; W Zhang; X-X Cao; T-N Zhu; J-L Zhuang; B Han; H Cai; H-C Cai; D-B Zhou
Journal:  Leukemia       Date:  2017-01-19       Impact factor: 11.528

5.  Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation.

Authors:  Barbara Vannata; Luca Laurenti; Patrizia Chiusolo; Federica Sorà; Mario Balducci; Mario Sabatelli; Marco Luigetti; Claudia Giannotta; Valerio De Stefano; Giuseppe Leone; Simona Sica
Journal:  Am J Hematol       Date:  2012-04-10       Impact factor: 10.047

6.  Cerebral infarction in POEMS syndrome: incidence, risk factors, and imaging characteristics.

Authors:  S A Dupont; A Dispenzieri; M L Mauermann; A A Rabinstein; R D Brown
Journal:  Neurology       Date:  2009-10-20       Impact factor: 9.910

7.  Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome.

Authors:  S Kuwabara; S Misawa; K Kanai; Y Suzuki; Y Kikkawa; S Sawai; T Hattori; M Nishimura; C Nakaseko
Journal:  Neurology       Date:  2008-10-01       Impact factor: 9.910

8.  Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment.

Authors:  T V Kourelis; F K Buadi; M A Gertz; M Q Lacy; S K Kumar; P Kapoor; R S Go; J A Lust; S R Hayman; V Rajkumar; S R Zeldenrust; S J Russell; D Dingli; Y Lin; N Leung; Y L Hwa; W Gonsalves; R A Kyle; A Dispenzieri
Journal:  Leukemia       Date:  2015-12-16       Impact factor: 11.528

9.  Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.

Authors:  Angela Dispenzieri; Martha Q Lacy; Suzanne R Hayman; Shaji K Kumar; Francis Buadi; David Dingli; Mark R Litzow; Dennis A Gastineau; David J Inwards; Michelle A Elliott; Ivana N Micallef; Stephen M Ansell; William J Hogan; Luis F Porrata; Patrick A Johnston; Bekele Afessa; Alan Bryce; Robert A Kyle; Morie A Gertz
Journal:  Eur J Haematol       Date:  2008-01-23       Impact factor: 2.997

10.  Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.

Authors:  S Misawa; Y Sato; K Katayama; H Hanaoka; S Sawai; M Beppu; F Nomura; K Shibuya; Y Sekiguchi; Y Iwai; K Watanabe; H Amino; C Ohwada; M Takeuchi; E Sakaida; C Nakaseko; S Kuwabara
Journal:  BMJ Open       Date:  2015-11-11       Impact factor: 2.692
View more
  6 in total

1.  Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma.

Authors:  Ankit Kansagra; Angela Dispenzieri; Raphael Fraser; Noel Estrada-Merly; Surbhi Sidana; Taiga Nishihori; Doris K Hansen; Larry D Anderson; Rahul Banerjee; Naresh Bumma; Binod Dhakal; Jack Khouri; Heather Landau; Cindy Lee; Hira Mian; Sunita Nathan; Bipin Savani; Shaji Kumar; Muzaffar Qazilbash; Nina Shah; Anita D'Souza
Journal:  Blood Adv       Date:  2022-07-12

2.  Treatment and outcomes of POEMS syndrome: changes in the past 20 years.

Authors:  Yan-Ying Yu; Xue-Min Gao; Hao Zhao; Hao Cai; Jun Feng; Lu Zhang; Xin-Xin Cao; Daobin Zhou; Jian Li
Journal:  Blood Cancer J       Date:  2021-08-14       Impact factor: 11.037

Review 3.  Update on the POEMS syndrome.

Authors:  Yu Ri Kim
Journal:  Blood Res       Date:  2022-04-30

4.  Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report.

Authors:  Ryutaro Taenaka; Sakurako Shimokawa; Ayako Katayama; Toshihiko Nagao; Teppei Obara; Naoaki Nishimura; Atsushi Tsujimoto; Kentaro Kohno; Kenichi Aoki; Ryosuke Ogawa
Journal:  J Med Case Rep       Date:  2022-08-18

5.  Efficacy of novel agents in patients with nephropathy associated with POEMS syndrome.

Authors:  Shuiqin Cheng; Li Huang; Wenjing Fan; Dandan Liang; Xiaodong Zhu; Song Jiang; Yongchun Ge
Journal:  Int Urol Nephrol       Date:  2022-02-08       Impact factor: 2.266

6.  Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.

Authors:  Tomoki Suichi; Sonoko Misawa; Yukari Sekiguchi; Kazumoto Shibuya; Keigo Nakamura; Hiroki Kano; Yuya Aotsuka; Ryo Otani; Marie Morooka; Shokichi Tsukamoto; Yusuke Takeda; Naoya Mimura; Chikako Ohwada; Emiko Sakaida; Satoshi Kuwabara
Journal:  Intern Med       Date:  2022-09-01       Impact factor: 1.282
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.